| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/28/1993 | US5248680 Zwitterionic compounds and their n-halo derivatives for use in the treatment of clinical conditions |
| 09/28/1993 | US5248606 Dna encoding inactive precursor and active forms of maize ribosome inactivating protein |
| 09/28/1993 | CA1322527C Compositions and methods of effecting contraception |
| 09/25/1993 | CA2091978A1 Pharmaceutical compounds |
| 09/24/1993 | CA2092108A1 Halichondrins |
| 09/22/1993 | EP0561496A2 cDNAs encoding the gastrin and CCK-B receptors |
| 09/22/1993 | EP0561424A1 Dehydrated liposomes |
| 09/22/1993 | EP0561303A2 Conjugates of phenylalanine-glycine with antitumor substances |
| 09/22/1993 | EP0561183A1 Anti-ganglioside monoclonal antibody, its preparation and use as a tumour therapeutic agent |
| 09/22/1993 | EP0561090A1 Process for the preparation of poor-digestible polysaccharides, possibly hydrogenated |
| 09/22/1993 | EP0560947A1 Tri- and tetra-valent monospecific antigen-binding proteins |
| 09/22/1993 | EP0560913A1 Bifunctional inhibitors of thrombin and platelet activation |
| 09/22/1993 | EP0440740B1 Radiotherapeutic immunoconjugates labeled with iodine-125 |
| 09/22/1993 | EP0247071B1 Immunotherapeutic treatment |
| 09/22/1993 | CN1076447A Antitumor compositions and methods of treatment |
| 09/22/1993 | CN1076444A Imidazolyl-substituted phenylacetamides |
| 09/22/1993 | CN1076358A Methods and compositions for reducing multi-drug resistance |
| 09/22/1993 | CN1022184C Process for preparing (1 H-imidzol-1-ylmethyl) substituted benzotriazole derivatives |
| 09/21/1993 | US5247070 N-terminal muteins of tumor necrosis factor |
| 09/21/1993 | US5246952 Heteroarylmethylbenzenes |
| 09/21/1993 | US5246700 In patients suffering from malignant tumors, interleukin-4 |
| 09/21/1993 | US5246691 Antitumor |
| 09/21/1993 | CA1322341C Method for the preparation of antibody-fragment conjugates |
| 09/21/1993 | CA1322332C Protein c inhibitor (pci) as pharmaceutical and diagnostic aid a process for the preparation of a pharmaceutical or diagnostic aid of this type, and an agent containing pci |
| 09/16/1993 | WO1993018152A1 Mn gene and protein |
| 09/16/1993 | WO1993018150A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | WO1993018057A1 4-oxo-2 thioxoimidazolidine derivates as inhibitors of blood platelet aggregation |
| 09/16/1993 | WO1993018024A1 1-alkoxy-2-(alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | WO1993017715A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells |
| 09/16/1993 | WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts |
| 09/16/1993 | WO1993017690A1 Halichondrins and related compounds |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/16/1993 | CA2452130A1 Methods and compositions for targeting the vasculature of solid tumors |
| 09/16/1993 | CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 09/16/1993 | CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor |
| 09/16/1993 | CA2130905A1 Halichondrins and related compounds |
| 09/15/1993 | EP0560554A2 Antitumor compositions and methods of treatment |
| 09/15/1993 | EP0560389A1 Lactone with immunosuppressive activity |
| 09/15/1993 | EP0560227A2 Epstein-barr virus activation inhibitor from lichens |
| 09/15/1993 | EP0560162A1 Imidazolylmethyl substituted phenylacetic-acid amides, process for their preparation and their pharmaceutical application |
| 09/15/1993 | EP0560149A1 BU-4641V, an antibacterial antiviral and antitumor antibiotic |
| 09/15/1993 | EP0559838A1 Ecteinascidins 736 and 722. |
| 09/15/1993 | CN1076186A Cryogenic rectification system with argon heat pump |
| 09/15/1993 | CA2091316A1 Phenylalanine-glycine derivatives, process for preparation thereof, and pharmaceutical composition containing said derivatives |
| 09/14/1993 | US5245061 Anticancer agents |
| 09/14/1993 | US5244914 Stable porfimer sodium compositions and methods for their manufacture |
| 09/14/1993 | US5244903 Camptothecin analogs as potent inhibitors of topoisomerase I |
| 09/14/1993 | US5244886 11β-phenyl-14βH steroids |
| 09/14/1993 | US5244671 Derivatives of porphycene for photodynamic therapy of cancer |
| 09/14/1993 | US5244662 Medicinal extract from a mixture of phellodendron and defatted seed of croton, and method for it's manufacture |
| 09/14/1993 | CA2091435A1 Imidazolyl-substituted phenylacetamides |
| 09/14/1993 | CA2091207A1 Antitumor compositions and methods of treatment |
| 09/14/1993 | CA1322195C Acetylenic, cyano and allenic aristeromycin/adenosine derivatives |
| 09/14/1993 | CA1322158C Uses of recombinant colony stimulating factor-1 |
| 09/14/1993 | CA1322157C Bifunctional proteins |
| 09/09/1993 | DE4207254A1 4-oxo-2-thioxoimidazolidin-derivate 4-oxo-2-thioxoimidazolidin-derivatives |
| 09/08/1993 | EP0559428A2 Novel polypeptides and DNAs encoding them |
| 09/08/1993 | EP0559055A1 N-Deacetyl lysogangliosides for use as medicaments |
| 09/08/1993 | EP0559019A1 14-beta-hydroxy-10-deacytyl-baccatine III and its derivatives as antitumour agents |
| 09/08/1993 | EP0559018A1 Taxane derivatives, their preparation and use in oncology |
| 09/08/1993 | EP0558962A1 Use of a tyrosine protein kinase inhibitor for treating cancer |
| 09/08/1993 | EP0558959A1 Phosphonooxy and carbonate derivatives of taxol |
| 09/08/1993 | EP0558950A1 3-aryl-glycidic ester derivatives and process for their preparation |
| 09/08/1993 | EP0558753A1 Beta-glucuronidase inhibitor |
| 09/08/1993 | EP0558749A1 Antisense nucleic acid derivative |
| 09/08/1993 | EP0558681A1 Treatment for tissue ulceration |
| 09/08/1993 | EP0558648A1 Improved matrix metalloprotease inhibitors |
| 09/08/1993 | EP0558623A1 Method for preparing taxane derivatives, novel derivatives thereby obtained and pharmaceutical compositions containing same. |
| 09/08/1993 | CN1075966A Chelate and preparation thereof |
| 09/08/1993 | CN1075961A Antitumor compositions and methods of treatment |
| 09/08/1993 | CN1075886A Medicine for curing liver cancer and its making method |
| 09/08/1993 | CN1022038C Method for preparation of 4-demethoxy-4-amino anthrancene compounds |
| 09/07/1993 | US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them |
| 09/07/1993 | US5243045 Certain alkoxy substituted taxanes and pharmaceutical compositions containing them |
| 09/07/1993 | US5242925 Piperazinylbenzodioxane derivatives |
| 09/07/1993 | US5242909 Anticarcinogenic agents and antitumor agents |
| 09/07/1993 | US5242824 Monoclonal antibody to human carcinomas |
| 09/07/1993 | US5242813 Mouse monoclonal antibodies specific for normal primate tissue, malignant human cultural cell lines human tumors |
| 09/07/1993 | US5242810 Bifunctional inhibitors of thrombin and platelet activation |
| 09/07/1993 | US5242692 Anti-metastatic factor |
| 09/07/1993 | CA2057021C Therapeutic application of an anti-invasion compound |
| 09/07/1993 | CA1322077C Process for synthesis of aminomethylene phosphonoalkylphosphinates |
| 09/07/1993 | CA1322076C Phosphorus containing peptides |
| 09/06/1993 | CA2090957A1 Anti-tumor method and anti-tumor agent |
| 09/04/1993 | CA2090639A1 Polypeptides and dnas encoding them |
| 09/02/1993 | WO1993017041A1 Car receptors and related molecules and methods |
| 09/02/1993 | WO1993017033A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | WO1993017021A1 Heterocyclic compounds for enhancing antitumor activity |
| 09/02/1993 | WO1993017008A1 3-ALKYLOXY-, ARYLOXY-, OR ARYLALKYLOXYBENZO[b]THIOPHENE-2-CARBOXAMIDES AS INHIBITORS OF CELL ADHESION |
| 09/02/1993 | WO1993016982A1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 09/02/1993 | WO1993016978A1 Ketotricyclo(5.2.1.0)decane derivates |
| 09/02/1993 | WO1993016733A1 Topical composition containing hyaluronic acid and nsaids |
| 09/02/1993 | WO1993016718A1 Hepatoma treatment with somatostatin analogs |
| 09/02/1993 | WO1993016704A1 Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof |
| 09/02/1993 | WO1993016702A1 Quinobenzoxazine, quinobenzothiazine, and pyrido-acridine antineoplastic agents |
| 09/02/1993 | WO1993016690A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | CA2129987A1 Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| 09/02/1993 | CA2129732A1 Cytoprotective compositions containing pyruvate and antioxidants |
| 09/02/1993 | CA2129337A1 Heterocyclic compounds for enhancing antitumor activity |
| 09/02/1993 | CA2128998A1 Bicyclo¬2.2.2.|octane derivatives as cholestocystokinin inhibitors |